EPICOVIDEHA: A Ready to Use Platform for Epidemiological Studies in Hematological Patients With COVID-19

• Jon Salmanton-García,
• Alessandro Busca,
• Oliver A. Cornely,
• Paolo Corradini,
• Martin Hoenigl,
• Nikolai Klimko,
• Francesco Marchesi,
• Antonio Pagliuca,
• Francesco Passamonti,
• Philipp Koehler,
• Livio Pagano

Affiliations

Jon Salmanton-García

1 Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Excellence Center for Medical Mycology (ECMM), Cologne, Germany

Alessandro Busca

3 Stem Cell Transplant Center, AOU Citta’ della Salute e della Scienza, Turin, Italy

Oliver A. Cornely

1 Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Excellence Center for Medical Mycology (ECMM), Cologne, Germany

Paolo Corradini

7 University of Milan & Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

Martin Hoenigl

8 Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California San Diego, CA, USA

Nikolai Klimko

11 Department of Clinical Mycology, Allergy and Immunology, North Western State Medical University, St Petersburg, Russia

Francesco Marchesi

12 Hematology and Stem Cell Transplant Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy

Antonio Pagliuca

13 Department of Hematological Medicine, Kings College Hospital NHS Foundation Trust, London, United Kingdom

Francesco Passamonti

14 Department of Medicine and Surgery, University of Insubria and ASST Sette Laghi, Ospedale di Circolo of Varese, Italy

Philipp Koehler

1 Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Excellence Center for Medical Mycology (ECMM), Cologne, Germany

Livio Pagano

15 Hematology, Fondazione Policlinico Universitario Agostino Gemelli - IRCCS, Rome, Italy